2213-2600
38.7
是
不在预警名单内
否
Q1区
0
医学
ENGLAND
Elsevier Ltd
SCIE,Scopus
95
2.85
-
The Lancet Respiratory Medicine delivers comprehensive, clinically-focused coverage on all areas of respiratory medicine and critical care, including but not limited to: COPD, asthma, cystic fibrosis, IPF, pneumonia, influenza, tuberculosis, sarcoidosis, pulmonary hypertension, sleep medicine, respiratory infections, pulmonary vascular disease, lung cancer, tobacco control, thoracic and reconstructive surgery, mesothelioma, and palliative medicine. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Respiratory Medicine contains Original Research, Reviews, Personal Views, Comments, and News.The Lancet Respiratory Medicine is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks of submission (on average) and published Online First on www.thelancet.com before appearing in print.Now indexed in PubMed, Journal Citation Reports®, and Scopus, the journal accepts submissions of Original Research, Reviews, Personal Views, and Comments. Visit http://ees.elsevier.com/thelancetrm to learn more about our editorial scope and aims and to submit your manuscript.Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at www.thelancet.com.To find out more about The Lancet Respiratory Medicine, visit www.thelancet.com/respiratory.
《柳叶刀呼吸医学》提供全面的、以临床为重点的覆盖呼吸医学和重症监护的所有领域,包括但不限于:COPD、哮喘、囊性纤维化、IPF、肺炎、流感、结核病、结节病、肺动脉高压、睡眠药物、呼吸道感染、肺血管疾病、肺癌、烟草控制、胸外科和重建手术、间皮瘤和姑息性药物。《柳叶刀呼吸医学》秉承了《柳叶刀》出版影响医疗实践的高影响力内容的传统,每期月刊都包含原创研究、评论、个人观点、评论和新闻。《柳叶刀呼吸医学》经过严格编辑和同行评审,以确保其多样化内容的科学价值和临床相关性。原创研究在提交后8周内(平均)快速发布,并在印刷版发表前首先在www.example.com上在线发布www.thelancet.com。现在,该杂志在PubMed、Journal Citation Reports®和Scopus中编入索引,接受原创研究、评论、个人观点和评论的提交。请访问http://ees.elsevier.com/thelancetrm了解更多关于我们的编辑范围和目标的信息,并提交您的稿件。黄金或绿色开放获取适用于与爱思唯尔签订协议的选定资助机构支持的研究。中低收入国家的读者也可以通过HINARI计划或通过IP访问www.thelancet.com免费获得该杂志。要了解更多关于柳叶刀呼吸医学的信息,请访问www.thelancet.com/respiratory。
《Lancet Respiratory Medicine》期刊已被查看: 次
如果你是第一次发表SCI的话,我还是建议你啊,花钱找一个好的老师,一呢是让你尽快拿到一个结果,有一个好的开始啊,二是为了摸清套路,也对自己未来的科研路呢,能起到
JCR:Q2区--分类:医学
影响因子2.8
收录SCIE,Scopus,ssci
JCR:Q4区--分类:医学
影响因子0.6
收录SCIE,Scopus,DOAJ开放期刊
JCR:Q2区--分类:医学
影响因子1.8
收录SCIE,Scopus
JCR:Q1区--分类:医学
影响因子4.7
收录SCIE,Scopus
JCR:Q1区--分类:医学
影响因子3.4
收录SCIE,Scopus,ssci
JCR:Q4区--分类:医学
影响因子1.1
收录SCIE,Scopus
JCR:Q4区--分类:医学
影响因子0.4
收录SCIE,Scopus
JCR:Q4区--分类:医学
影响因子0.9
收录SCIE,Scopus